You are here

  • Home
  • Archive
  • Volume 9, Issue 7
  • Predictive value of 3′-deoxy-3′-18F-fluorothymidine PET in the early response to anti-programmed death-1 therapy in patients with advanced non-small cell lung cancer

Article metrics

Article menu
XML
Immunotherapy biomarkers
Original research
Predictive value of 3′-deoxy-3′-18F-fluorothymidine PET in the early response to anti-programmed death-1 therapy in patients with advanced non-small cell lung cancer

 

Online download statistics by month:

Online download statistics by month: July 2021 to January 2026

AbstractFullPdf
Jul 202120220398
Aug 202113013057
Sep 2021989845
Oct 202110710730
Nov 202111711747
Dec 2021757520
Jan 2022485121
Feb 2022272811
Mar 202210711620
Apr 2022515416
May 2022404220
Jun 2022546015
Jul 2022384429
Aug 2022434621
Sep 2022444528
Oct 2022384222
Nov 2022303019
Dec 202220209
Jan 2023222211
Feb 2023626419
Mar 2023172030
Apr 2023181817
May 2023192011
Jun 2023464625
Jul 2023161615
Aug 202317174
Sep 2023262613
Oct 2023444419
Nov 2023545411
Dec 20239999178
Jan 2024151696
Feb 2024171713
Mar 2024202040
Apr 2024272829
May 202420207
Jun 2024242312
Jul 2024464718
Aug 2024333319
Sep 2024242416
Oct 2024252715
Nov 2024373815
Dec 2024384011
Jan 2025303012
Feb 2025212115
Mar 202534368
Apr 2025535319
May 2025373813
Jun 2025272714
Jul 2025110
Aug 2025110
Jan 2026110
Total224022951253